Treatment Characteristics and Healthcare Resource Utilization Among Patients with Myasthenia Gravis Initiating Rozanolixizumab: A US Claims Database Analysis.
- DOI
- 10.1007/s40120-026-00939-7
- Published
- 2026 Aug
- Container
- Neurology and therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s40120-026-00939-7,
title = {Treatment Characteristics and Healthcare Resource Utilization Among Patients with Myasthenia Gravis Initiating Rozanolixizumab: A US Claims Database Analysis.},
author = {Kumar M and Harrold A and Park M and Nair A and Bardenheuer K and Tarancón T and Ting A and Pata D},
year = {2026},
journal = {Neurology and therapy},
doi = {10.1007/s40120-026-00939-7},
url = {https://doi.org/10.1007/s40120-026-00939-7}
}RIS
TY - JOUR TI - Treatment Characteristics and Healthcare Resource Utilization Among Patients with Myasthenia Gravis Initiating Rozanolixizumab: A US Claims Database Analysis. AU - Kumar M AU - Harrold A AU - Park M AU - Nair A AU - Bardenheuer K AU - Tarancón T AU - Ting A AU - Pata D PY - 2026 JO - Neurology and therapy DO - 10.1007/s40120-026-00939-7 UR - https://doi.org/10.1007/s40120-026-00939-7 ER -
APA
M, K., A, H., M, P., A, N., K, B., T, T., A, T., & D, P. (2026). Treatment Characteristics and Healthcare Resource Utilization Among Patients with Myasthenia Gravis Initiating Rozanolixizumab: A US Claims Database Analysis.. Neurology and therapy. https://doi.org/10.1007/s40120-026-00939-7
Source records
- pubmed · retrieved 2026-09-26T12:02:56.249Z